Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Desmoid Tumors Market, and What Factors Will Drive It?
The market size for desmoid tumors has seen a robust growth lately. The projection shows a growth from $2.97 billion in 2024 to $3.15 billion in 2025, displaying a compound annual growth rate (CAGR) of 6.3%. This notable increase over the historic period can be credited to the progress in medical imaging, genetic studies and understanding, revolutionary surgical procedures, patient advocacy, awareness and education.
The market size for desmoid tumors is predicted to experience significant growth in the upcoming years, expected to reach $4.08 billion by 2029 with a compound annual growth rate (CAGR) of 6.7%. This growth during the forecast period can be credited to factors such as personalized treatments, targeted therapies, increased global collaborations, regulatory sanctioning for innovative therapies, and patient-focused approaches. Major trends that will shape the forecast period include progress in treatment strategies, precision medicine, biomarker identification, clinical studies, research efforts, multidisciplinary therapeutic teams, and patient advocacy and support.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13228&type=smp
What Are the Core Growth Drivers Propelling the Desmoid Tumors Market Forward?
The escalation in cancer cases is predicted to amplify the expansion of the desmoid tumor market in the future. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which have the potential to invade and damage surrounding structures and organs. The increasing incidence of cancer globally is intensifying the need for effective and innovative chemotherapy drugs, thereby driving the desmoid tumor market’s growth. For instance, the National Cancer Institute, a U.S federal government agency, reported in May 2024, about 2,001,140 new cancer diagnoses can be expected in the U.S., accompanied by an estimated 611,720 fatalities due to the ailment. In 2022, approximately 20 million new cases and 9.7 million cancer-related deaths were reported worldwide. By 2040, the annual new cancer cases are projected to ascend to 29.9 million, and cancer-related deaths to 15.3 million. Consequently, the escalating prevalence of cancer is propelling the growth of the desmoid tumor market.
What Segment Types Define the Desmoid Tumors Market Structure?
The desmoid tumorsmarket covered in this report is segmented –
1) By Treatment: Surgery; Radiation Therapy; Anti-Inflammatory Medication; Hormone Therapy; Chemotherapy; Novel Molecular-Targeted Therapy; Other Treatments
2) By Diagnosis: Biopsy; Electron Microscopic Examination; Immunohistochemical Analysis; Other Diagnosis
3) By End-User: Hospitals And Clinics; Specialty Centers; Other End-Users
Subsegments:
1) By Surgery: Wide Excision; Minimally Invasive Surgery
2) By Radiation Therapy: External Beam Radiation Therapy; Stereotactic Body Radiation Therapy
3) By Anti-Inflammatory Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroids
4) By Hormone Therapy: Selective Estrogen Receptor Modulators (SERMs); Aromatase Inhibitors
5) By Chemotherapy: Traditional Chemotherapy Agents; Combination Chemotherapy
6) By Novel Molecular-Targeted Therapy: Tyrosine Kinase Inhibitors; Other Targeted Therapies
7) By Other Treatments: Watchful Waiting; Physical Therapy; Pain Management Strategies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13228&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Desmoid Tumors Market?
North America was the largest region in the desmoid tumors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the desmoid tumors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Emerging Trends that Are Influencing theDesmoid Tumors Industry Evolution?
Major firms involved in the desmoid tumors market, such as SpringWorks Therapeutics Inc., are working on innovative medical solutions like nirogacestat to enhance the treatment of desmoid tumors for their consumers. Nirogacestat is a gamma-secretase inhibitor that is orally administered and small in molecular size. For example, in February 2023, SpringWorks Therapeutics Inc., announced that the U.S. Food and Drug Administration (FDA) accepted their new drug application (NDA) for nirogacestat and gave it priority review status. The drug is believed to function by inhibiting the production of notch proteins that could cause tumor cells to die. It’s worth noting that desmoid tumors are known to generate excessive levels of notch protein, a factor that could contribute to their proliferation. Furthermore, nirogacestat offers patients an additional treatment alternative that may enhance their chances of recovery.
View the full report here:
https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report
What Is the Definition of the Desmoid Tumors Market?
Desmoid tumors refer to rare non-cancerous (benign) tumors that arise from connective tissue cells, usually in the fascia, which is the tissue that surrounds muscles, nerves, and blood vessels. These tumors are locally aggressive, which means they can grow and invade nearby structures but do not spread to distant parts of the body like traditional cancer.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13228
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model